Changjiang Pharmaceutical Group Co., Ltd. (SHE:300391)
China flag China · Delayed Price · Currency is CNY
0.1900
0.00 (0.00%)
Inactive · Last trade price on Apr 10, 2026

SHE:300391 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Revenue
116.07111.631,1981,6152,3621,215
Revenue Growth
-58.05%-90.68%-25.86%-31.61%94.48%67.45%
Gross Profit
-12.7-8.56171.2327.3527.79260.59
Operating Income
-793.28-761.21-138.4882.36251.1478.76
Net Income
-656.72-627.96-605.65-23.2749.125.32
Earnings Per Share
-1.87-1.79-1.73-0.070.140.07
EPS Growth
----93.91%-

Revenue by Segment

Fiscal YearTTMFY 2024FY 2023FY 2023FY 2022FY 2020
Period EndingSep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Photovoltaic Industry
-63.84126.85154.45330.74507.16
Pharmaceutical Industry/Medical Industry
-47.781,0711,2691,558292.37
Total
253.61111.631,1981,6152,3621,215

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Investments
21.748.315.217.47107.7139.92
Total Debt
639.691,1981,2201,020951.04992.19
Net Cash (Debt)
-617.95-1,189-1,204-1,002-843.34-852.27
Net Cash Growth
------
Net Cash Per Share
-1.76-3.39-3.44-2.86-2.41-2.43

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Cash Flow
-176.58-75.3-147.43-66.08230.9932.81
Capital Expenditures
1.32-4.21-6.79-51.47-142.26-18.82
Free Cash Flow
-175.26-79.51-154.22-117.5588.7213.98
Free Cash Flow Growth
----534.44%-18.05%

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Gross Margin
-10.94%-7.66%14.29%20.26%22.35%21.46%
Operating Margin
-683.43%-681.93%-11.56%5.10%10.63%6.49%
Pretax Margin
-1201.21%-1279.03%-56.87%4.45%6.70%4.81%
Profit Margin
-565.78%-562.56%-50.57%-1.44%2.08%2.08%
FCF Margin
-150.99%-71.23%-12.88%-7.28%3.76%1.15%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
PE Ratio
----108.44169.77
Forward PE
-14.6714.6714.6714.6714.67
P/FCF Ratio
----60.02307.38
PS Ratio
0.5715.822.262.122.263.54